Inhibition of constitutive NF-κB activity suppresses tumorigenicity of ewing sarcoma EW7 cells

International Journal of Cancer

Volumn 98, Issue 2, 2002, Pages 193-198

  Javelaud, Delphine ^a   Poupon, Marie France ^b   Wietzerbin, Juana ^a   Besançon, Françoise ^a,c  

^a INSERM   (France)

^b CNRS   (France)

^c INSTITUT CURIE   (France)

Author keywords

Cancer therapy; Ewing sarcoma; NF B; Transcription factor; Tumorigenicity

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; SCLEROPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; EWING SARCOMA; FEMALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; SARCOMA CELL; TUMOR GROWTH;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; APOPTOSIS; BONE NEOPLASMS; CELL DIVISION; DNA-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENES, REPORTER; HUMANS; I-KAPPA B PROTEINS; KINETICS; MICE; MICE, NUDE; NF-KAPPA B; RNA, NEOPLASM; SARCOMA, EWING'S; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037051098     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10192     Document Type: Article

References (35)

1. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors
2. A second Ewing sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG
3. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts
4. Ewing sarcoma and peripheral primitive neuroectodermal tumors after their genetic union
5. Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family
6. The Ewing family of tumors and the search for the Achilles heel
7. NF-κB: 10 Years after
8. Activators and target genes of Rel/NF-κB transcription factors
9. Catalysis by a multiprotein IκB kinase complex
10. NF-κB activation: The IκB kinase revealed?
11. How NF-κB is activated: The role of the IκB kinase (IKK) complex
12. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli
13. Rel/NF-κB/I κB family: Intimate tales of association and dissociation
14. Aberrant rel/NFκB genes and activity in human cancer
15. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
16. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
17. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation
18. A requirement for NF-κB activation in Bcr-Abl-mediated transformation
19. Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of IκBα/MAD3
20. Induction of p21Waf1 Cip1 by TNFα requires NF-κB activity and antagonizes apoptosis in Ewing tumor cells
21. Response of small cell lung cancer xenografts to chemotherapy: Multidrug resistance and direct clinical correlates
22. Production and characterization of mouse monoclonal antibodies to wildtype and oncogenic FLI-1 proteins
23. NK cells and apoptosis
24. Cytokines (IFNs, TNF-alpha, IL-2 and IL-12) and animal models of cancer
25. Selective activation of NF-κB subunits in human breast cancer: Potential roles for NF-κB2 and for Bcl-3
26. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1
27. NF-κB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition
28. Blockade of nuclear factor-κB signaling inhibits angiogenesis and tumorigenicity of ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
29. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis
30. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors
31. Regulation of matrix metalloproteinase expression in tumor invasion
32. Control of apoptosis by Rel/NF-κB transcription factors
33. Evidence for a role of NF-κB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor β fusion protein
34. Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo
35. Clinical applications of TNF-α in cancer